# Green Tea Extract Blood Pressure Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/green-tea-extract-blood-pressure-meta-analysis-evidence-review
Category: evidence-review
Summary: Green Tea Extract Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first p
Last reviewed: 2026-05-27
Reviewed by: Migaku Evidence Review
# Green Tea Extract Blood Pressure Meta-analysis: What the Evidence Says

## Quick Answer

Green Tea Extract Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 randomized trial.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Herbal compounds in the treatment of polycystic ovary syndrome: an updated systematic review | systematic review | 1 | 2026-02-27 | 10.1186/s13048-026-02030-z |
| Effects of Green Tea–Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8‐Week Randomized Controlled Trial | randomized trial | 2 | 2026-04-07 | 10.1155/jnme/2301278 |

## What The Sources Report

- PCOS increases the risk of other disorders, including type 2 diabetes, dyslipidemia, high blood pressure, cancers, infertility, and metabolic diseases such as insulin resistance. [Dashti Sareh (2026); evidence level 1]
- Conventional pharmacological interventions, such as hormonal contraceptives, insulin sensitizers, and ovulation-inducing agents are effective in symptom control, but may be associated with side effects, contraindications, or limited patient adherence. [Dashti Sareh (2026); evidence level 1]
- The risk of NCDs such as diabetes and cardiovascular disease increases with aging due to a progressive decline in metabolic function. [Fuke Saeka (2026); evidence level 2]
- The World Health Organization identifies elevated blood glucose level and abnormal lipid profiles as key risk factors for NCDs. [Fuke Saeka (2026); evidence level 2]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. There is trial evidence in the current set, but population and intervention details still matter. For green tea extract blood pressure meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Dashti Sareh (2026). Herbal compounds in the treatment of polycystic ovary syndrome: an updated systematic review. DOI: 10.1186/s13048-026-02030-z. PMCID: PMC13041406. PMID: 41761211. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13041406/
- Fuke Saeka (2026). Effects of Green Tea–Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8‐Week Randomized Controlled Trial. DOI: 10.1155/jnme/2301278. PMCID: PMC13054514. PMID: 41952965. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13054514/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.